BG104533A - Ген за психоматични разстройства - Google Patents

Ген за психоматични разстройства Download PDF

Info

Publication number
BG104533A
BG104533A BG104533A BG10453300A BG104533A BG 104533 A BG104533 A BG 104533A BG 104533 A BG104533 A BG 104533A BG 10453300 A BG10453300 A BG 10453300A BG 104533 A BG104533 A BG 104533A
Authority
BG
Bulgaria
Prior art keywords
disorder
dna
sequence
yac
gene
Prior art date
Application number
BG104533A
Other languages
Bulgarian (bg)
English (en)
Inventor
Peter Raeymaekers
Broeckhoven Christine Van
Jurgen Del-Favero
Original Assignee
Vlaams Interuniversitair Instituut Voor Biotechnologie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vlaams Interuniversitair Instituut Voor Biotechnologie filed Critical Vlaams Interuniversitair Instituut Voor Biotechnologie
Publication of BG104533A publication Critical patent/BG104533A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
BG104533A 1997-12-18 2000-06-15 Ген за психоматични разстройства BG104533A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9726804.9A GB9726804D0 (en) 1997-12-18 1997-12-18 Mood disorder gene
PCT/EP1998/008543 WO1999032643A2 (en) 1997-12-18 1998-12-17 Mood disorder gene

Publications (1)

Publication Number Publication Date
BG104533A true BG104533A (bg) 2001-04-30

Family

ID=10823856

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104533A BG104533A (bg) 1997-12-18 2000-06-15 Ген за психоматични разстройства

Country Status (13)

Country Link
EP (1) EP1038015B1 (de)
JP (1) JP2001526897A (de)
AT (1) ATE329044T1 (de)
AU (1) AU2514999A (de)
BG (1) BG104533A (de)
CA (1) CA2314437A1 (de)
DE (1) DE69834831T2 (de)
ES (1) ES2262256T3 (de)
GB (1) GB9726804D0 (de)
HU (1) HUP0100409A3 (de)
PL (1) PL341814A1 (de)
TR (1) TR200001965T2 (de)
WO (1) WO1999032643A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003532073A (ja) * 2000-04-25 2003-10-28 スペクトラメディックス コーポレイション 高温条件下での生体分子の変性剤−フリー電気泳動

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997011175A1 (en) * 1995-09-23 1997-03-27 Medical Research Council Screening for disorders of serotonergic dysfunction
FR2741088B1 (fr) * 1995-11-10 1998-01-30 Centre Nat Rech Scient Methode de traitement de maladies neurodegeneratives mettant en oeuvre un anticorps ic2, un fragment ou derive de celui-ci et compositions pharmaceutiques correspondantes
WO1997037043A1 (en) * 1996-03-29 1997-10-09 The Regents Of The University Of California Methods for treating bipolar mood disorder associated with markers on chromosome 18q

Also Published As

Publication number Publication date
EP1038015A2 (de) 2000-09-27
DE69834831T2 (de) 2007-02-01
EP1038015B1 (de) 2006-06-07
PL341814A1 (en) 2001-05-07
CA2314437A1 (en) 1999-07-01
TR200001965T2 (tr) 2000-12-21
ATE329044T1 (de) 2006-06-15
GB9726804D0 (en) 1998-02-18
WO1999032643A3 (en) 1999-10-21
JP2001526897A (ja) 2001-12-25
DE69834831D1 (de) 2006-07-20
AU2514999A (en) 1999-07-12
HUP0100409A2 (hu) 2001-06-28
WO1999032643A2 (en) 1999-07-01
ES2262256T3 (es) 2006-11-16
HUP0100409A3 (en) 2003-09-29

Similar Documents

Publication Publication Date Title
Flavigny et al. Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy
Rehman et al. Mutations in TBC1D24, a gene associated with epilepsy, also cause nonsyndromic deafness DFNB86
JP4723550B2 (ja) 生存運動ニューロン（ｓｍｎ）遺伝子；脊髄筋萎縮
Hes et al. Genotype-phenotype correlations in families with deletions in the von Hippel-Lindau (VHL) gene
Jeschke et al. A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated β-myosin heavy chain genes
KR20000062427A (ko) 질병의 대규모 유전자형 식별방법 및 척수소뇌성 운동실조 타입 6의 진단방법
US6566064B1 (en) Method for anticipating sensitivity to medicine for osteoporosis
AU693562B2 (en) Method and probes for detecting markers bound to the locus of child spinal muscular atrophies
Kanters et al. Novel donor splice site mutation in the KVLQT1 gene is associated with long QT syndrome
Growney et al. Evolutionary divergence of the mouse and human Lgn1/SMA repeat structures
EP0711833A2 (de) Motorneuronlebenserhaltungsgen: ein Gen für spinale Muskelatrophie
BG104533A (bg) Ген за психоматични разстройства
ZA200509945B (en) Methods for the diagnosis and prognosis of Alzheimer's disease
Moric-Janiszewska et al. Mutational screening of SCN5A linked disorders in Polish patients and their family members
JP4776841B2 (ja) 脈管形成分野におけるＫｒｉｔ１遺伝子の使用
CN115927354B (zh) 一种sh3tc2基因致病突变体及其在制备腓骨肌萎缩症4c型诊断试剂盒中的应用
JP2000316577A (ja) 成人発症ｉｉ型シトルリン血症の診断方法
Modibo et al. GENOTYPIC SPECTRUM OF ALBINISM IN MALI
US7803538B2 (en) Method for detecting Alzheimer's disease
Ging Investigating the Role of Modifiers in Trinucleotide Repeat Diseases
JP3684921B2 (ja) 骨粗鬆症薬剤感受性予測方法
CZ20002282A3 (cs) Gen asociovaný s poruchou nálady, jeho použití a způsob identifikace
JP4048555B2 (ja) 骨粗鬆症薬剤感受性予測方法
Bacchelli Investigating the molecular basis of Jeune and Cenani-Lenz syndromes
Goossens Cloning of candidate genes for bipolar disorder starting from expanded trinucleotide repeats